| NDC Code | 31722-365-31 |
|---|
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (31722-365-31) |
|---|
| Product NDC | 31722-365 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Azacitidine |
|---|
| Non-Proprietary Name | Azacitidine |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20241015 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA215765 |
|---|
| Manufacturer | Camber Pharmaceuticals, Inc. |
|---|
| Substance Name | AZACITIDINE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
|---|